FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204240483> ?p ?o ?g. }

• W3204240483 endingPage "1929" @default.
• W3204240483 startingPage "1917" @default.
• W3204240483 abstract "Pustular psoriasis is an unusual form of psoriasis that frequently presents clinical challenges for dermatologists. The condition presents with pustules on an erythematous background and has two distinct subtypes: localized disease on the palms and soles, called palmoplantar pustulosis (PPP), and generalized pustular psoriasis (GPP). The involvement of the fingers, toes, and nails is defined as a separate localized variant, acrodermatitis continua of Hallopeau, and is now thought to be a subset of PPP. The rarity of pustular psoriasis frequently makes the correct diagnosis problematic. In addition, treatment is limited by a relative lack of evidence-based therapeutic options. Current management is often based on existing therapies for standard plaque psoriasis. However, there remains a need for treatments with high, sustained efficacy and a rapid onset of action in pustular psoriasis. Recent advances in understanding of the pathogenesis of pustular psoriasis have provided insights into potential therapies. Treatment of pustular psoriasis is generally determined by the extent and severity of disease, and recent years have seen an increasing use of newer agents, including biologic therapies. Current classes of biologic therapies with US Food and Drug Administration and European Medicines Agency approval for treatment of moderate-to-severe plaque psoriasis in the USA (and elsewhere) include tumor necrosis factor alpha inhibitors (adalimumab, certolizumab pegol, etanercept, infliximab), interleukin (IL)-17 inhibitors (brodalumab, ixekizumab, secukinumab), an IL-12/23 inhibitor (ustekinumab), and IL-23 inhibitors (guselkumab, risankizumab, tildrakizumab). Recently, specific inhibitors of the IL-36 pathway have been evaluated in GPP and PPP, including spesolimab, an IL-36 receptor inhibitor which has shown promising results in GPP. The emerging drugs for pustular psoriasis offer the possibility of rapid and effective treatment with lower toxicities than existing therapies. Further research into agents acting on the IL-36 pathway and other targeted therapies has the potential to transform the future treatment of patients with pustular psoriasis. This article reviews the clinical features of PPP and GPP, and current understanding of the genetics and immunopathology of these conditions; it also provides an update on emerging treatments.Pustular psoriasis is a skin condition where people develop small pus-filled blisters on their skin. Pustular psoriasis may affect certain areas of the body, such as the palms and/or the soles. This is called palmoplantar pustulosis (PPP for short). Another type of pustular psoriasis can affect most of the body called generalized pustular psoriasis (GPP for short). Not many people have PPP or GPP. Around 5–12 in every 10,000 people worldwide develop PPP. GPP is even rarer, affecting only 2–7 out of every 1 million people. In addition to being relatively uncommon, these conditions are challenging to treat. This article aims to help doctors who treat skin conditions (dermatologists) to identify and treat people with pustular psoriasis. Currently there is no standard treatment for GPP and PPP in the USA or Europe, but several medicines are approved for treatment of GPP in Japan. Doctors often use treatments that have been shown to work in plaque psoriasis, which is the most common type of psoriasis, to treat people with GPP and PPP. Traditional treatments for PPP and GPP are often not effective. Researchers are working on developing new effective treatments for pustular psoriasis that may work more rapidly and have fewer side effects. These are expected to be available in the next few years." @default.
• W3204240483 created "2021-10-11" @default.
• W3204240483 creator A5031855679 @default.
• W3204240483 creator A5038764284 @default.
• W3204240483 creator A5075798284 @default.
• W3204240483 date "2021-10-09" @default.
• W3204240483 modified "2023-10-14" @default.
• W3204240483 title "Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options" @default.
• W3204240483 cites W1557055518 @default.
• W3204240483 cites W1589956668 @default.
• W3204240483 cites W1969908901 @default.
• W3204240483 cites W1972788947 @default.
• W3204240483 cites W1974012482 @default.
• W3204240483 cites W2005200020 @default.
• W3204240483 cites W2005876125 @default.
• W3204240483 cites W2007533329 @default.
• W3204240483 cites W2027969227 @default.
• W3204240483 cites W2035340451 @default.
• W3204240483 cites W2041437482 @default.
• W3204240483 cites W2064709295 @default.
• W3204240483 cites W2073577212 @default.
• W3204240483 cites W2084757225 @default.
• W3204240483 cites W2095667188 @default.
• W3204240483 cites W2129894969 @default.
• W3204240483 cites W2140341198 @default.
• W3204240483 cites W2143240524 @default.
• W3204240483 cites W2279719049 @default.
• W3204240483 cites W2336283515 @default.
• W3204240483 cites W2468433846 @default.
• W3204240483 cites W2514982855 @default.
• W3204240483 cites W2527420241 @default.
• W3204240483 cites W2530872160 @default.
• W3204240483 cites W2537971149 @default.
• W3204240483 cites W2565131287 @default.
• W3204240483 cites W2585102823 @default.
• W3204240483 cites W2762592199 @default.
• W3204240483 cites W2763258982 @default.
• W3204240483 cites W2769637877 @default.
• W3204240483 cites W2783191886 @default.
• W3204240483 cites W2794426555 @default.
• W3204240483 cites W2883167586 @default.
• W3204240483 cites W2886044341 @default.
• W3204240483 cites W2889429561 @default.
• W3204240483 cites W2890431055 @default.
• W3204240483 cites W2911486644 @default.
• W3204240483 cites W2912058252 @default.
• W3204240483 cites W2916036383 @default.
• W3204240483 cites W2921399822 @default.
• W3204240483 cites W2924217604 @default.
• W3204240483 cites W2947967529 @default.
• W3204240483 cites W2955497129 @default.
• W3204240483 cites W2971667944 @default.
• W3204240483 cites W2994163821 @default.
• W3204240483 cites W3000072935 @default.
• W3204240483 cites W3003765314 @default.
• W3204240483 cites W3006942965 @default.
• W3204240483 cites W3010998348 @default.
• W3204240483 cites W3011891394 @default.
• W3204240483 cites W3013779370 @default.
• W3204240483 cites W3015373497 @default.
• W3204240483 cites W3037606264 @default.
• W3204240483 cites W3040081948 @default.
• W3204240483 cites W3048569915 @default.
• W3204240483 cites W3134953187 @default.
• W3204240483 cites W4211153129 @default.
• W3204240483 cites W4319425402 @default.
• W3204240483 cites W989622084 @default.
• W3204240483 doi "https://doi.org/10.1007/s13555-021-00612-x" @default.
• W3204240483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34626330" @default.
• W3204240483 hasPublicationYear "2021" @default.
• W3204240483 type Work @default.
• W3204240483 sameAs 3204240483 @default.
• W3204240483 citedByCount "19" @default.
• W3204240483 countsByYear W32042404832021 @default.
• W3204240483 countsByYear W32042404832022 @default.
• W3204240483 countsByYear W32042404832023 @default.
• W3204240483 crossrefType "journal-article" @default.
• W3204240483 hasAuthorship W3204240483A5031855679 @default.
• W3204240483 hasAuthorship W3204240483A5038764284 @default.
• W3204240483 hasAuthorship W3204240483A5075798284 @default.
• W3204240483 hasBestOaLocation W32042404831 @default.
• W3204240483 hasConcept C142724271 @default.
• W3204240483 hasConcept C16005928 @default.
• W3204240483 hasConcept C17991360 @default.
• W3204240483 hasConcept C203014093 @default.
• W3204240483 hasConcept C2776215756 @default.
• W3204240483 hasConcept C2776260265 @default.
• W3204240483 hasConcept C2777138892 @default.
• W3204240483 hasConcept C2777226972 @default.
• W3204240483 hasConcept C2778975655 @default.
• W3204240483 hasConcept C2779134260 @default.
• W3204240483 hasConcept C2779745271 @default.
• W3204240483 hasConcept C2779786854 @default.
• W3204240483 hasConcept C2780132546 @default.
• W3204240483 hasConcept C2780564577 @default.
• W3204240483 hasConcept C2909516574 @default.
• W3204240483 hasConcept C71924100 @default.
• W3204240483 hasConceptScore W3204240483C142724271 @default.

• next